User Auth Test Page

Administration Will Make Coronavirus Vaccines “Immediately Available” To Children Under 12 Once FDA Authorized, CDC Head Says

CBS News (9/1, Zak) reports CDC Director Rochelle Walensky said the Biden Administration will make COVID-19 vaccines “immediately available” to children under age 12 once authorized by the FDA. Walensky said she “remains hopeful” young children will be ab...

Full Article
SARS-CoV-2 Antibody Testing: Where Are We Now?

Abstract Not Available

Full Article
Stat Laboratory Interventions To Improve Patient Management In The Emergency Department And Resource Expenditure: A 10-Year Study

Abstract Not Available

Full Article
Comparison Of Anti–SARS-CoV-2 S1 Receptor-Binding Domain Antibody Immunoassays In Health Care Workers Before And After The BNT162b2 MRNA Vaccine

Abstract Not Available

Full Article
WHO Monitoring Novel SARS-CoV-2 “Variant Of Interest”

The Hill (9/1, Choi) reports, “The World Health Organization (WHO) has designated the mu SARS-CoV-2 strain, first detected in Colombia, as a ‘variant of interest’ adding in its weekly bulletin that it will be monitoring the variant’s spread.” The WHO said...

Full Article
Results Of Self-Collected ANS, Saliva Samples Obtained Within Three To Seven Days Of COVID-19 Symptom Onset Show Sensitivity Of 80% Or Higher, Study Finds

Infectious Disease Advisor (9/1, Nye) reports, “Results of self-collected anterior nasal swab (ANS) and saliva samples obtained within 3 to 7 days of COVID-19 symptom onset showed a sensitivity of 80% or higher, according to” findings from a 1,916-patient...

Full Article
PEN-FAST Clinical Decision Tool May Assist In Efficient Amoxicillin Allergy Assessment, Results Show

Healio (8/31, Gawel) reports, “The PEN-FAST clinical decision tool can assist in efficient amoxicillin allergy assessment based on four recognizable features,” results published in Annals of Allergy, Asthma & Immunology demonstrate. Researchers in the 142...

Full Article
WHO Says More Tests Reveal Ivory Coast Did Not Have Ebola Case

The AP (9/1, N'gotta) reports, “New tests show that Ivory Coast did not have its first case of Ebola in more than 25 years after all, the World Health Organization said, reversing course after the reported case last month prompted thousands of vaccines to...

Full Article
Dolutegravir, NRTI Combination Effective Second-Line Treatment For Patients With HIV Infection, Results Show

Infectious Disease Advisor (9/1, Gupta) reports a combination of dolutegravir with nucleoside reverse-transcriptase inhibitors (NRTI) “was an effective second-line treatment for patients with HIV infection, including those with extensive NRTI resistance a...

Full Article
People Who Experience Breakthrough Infections After Full Vaccination About 50% Less Likely To Experience Long COVID, Study Finds

The New York Times (9/1, Anthes) reports, “People who experience breakthrough infections of the coronavirus after being fully vaccinated are about 50 percent less likely to experience long Covid than are unvaccinated people who catch the virus, researcher...

Full Article
Study Suggests Surgical Masks Limit COVID-19 Seroprevalence

The Washington Post (9/1, Taylor) reports that the “authors of a study based on an enormous randomized research project in Bangladesh say their results offer the best evidence yet that widespread wearing of surgical masks can limit the spread of the coron...

Full Article
Most Highly Allergic Individuals Can Be Safely Immunized Against COVID-19, Data Show

HealthDay (9/1) reports, “Most highly allergic individuals can be safely immunized against COVID-19, according to” researchers who “found that 97.9 percent of the patients from the highly allergic group had no immediate allergic event after the first dose...

Full Article
Some Physicians, Health Authorities Concerned With “Craze” For Ivermectin As COVID-19 Treatment

The Washington Post (9/1, Knowles, Gowen, Mark) reports some physicians and public health authorities “say they have spent the pandemic fighting rampant misinformation on top of a deadly virus,” but an ongoing “craze” for the anti-parasitic drug ivermecti...

Full Article
Drugmakers Announce New Trials For COVID-19 Drugs

Reuters (9/1, Beasley) reports Pfizer and Merck & Co “announced on Wednesday new trials of their experimental oral antiviral drugs for COVID-19.” Pfizer’s experimental therapy “is designed to block the activity of a key enzyme that is needed for the coron...

Full Article
HIV Vaccine Trial Shut Down After Shots Found To Offer Limited Protection

The New York Times (8/31, Nolen) reports an advanced trial in Africa testing an HIV vaccine developed by Johnson & Johnson “has been shut down after data showed the shots offered only limited protection against the virus, researchers announced on Tuesday....

Full Article
Assay Shows High Accuracy Rate For Detecting Presence Of Bacterial, Viral Infections In Patients Admitted To ED With Suspected Acute Infections Or Sepsis, Results Indicate

Infectious Disease Advisor (8/31, Gupta) reports “a novel 29-messenger RNA blood-based host-response assay” showed “high accuracy for detecting the presence of bacterial and viral infections among patients admitted to the emergency department (ED) with ei...

Full Article
Molecule In Brazilian Viper Venom Inhibits Coronavirus Reproduction In Monkey Cells, Study Shows

Reuters (8/31, Benassatto) reports, “Brazilian researchers have found that a molecule in the venom of a type of snake inhibited coronavirus reproduction in monkey cells, a possible first step toward a drug to combat the virus causing COVID-19.” The resear...

Full Article
Highly Mutated C.1.2 COVID-19 Variant Does Not Appear To Be Spreading, WHO Says

Newsweek (8/31, Fink) reports, “The World Health Organization (WHO) is aware of a potentially concerning COVID-19 variant in South Africa, but as of now, the new virus variant doesn’t appear to be spreading around the world.” South African researchers “fo...

Full Article
Moderna COVID-19 Vaccine Creates Double The Antibodies Of Pfizer/BioNTech Shot, Study Finds

The Hill (8/31, Coleman) reports new research “into the immune responses of the two mRNA COVID-19 vaccines found that Moderna’s vaccine created twice as many antibodies as the Pfizer-BioNTech vaccine.” According to the article, “Researchers analyzed the a...

Full Article
Prior COVID-19 Infection Alone May Not Guarantee High Level Of Antibodies Against SARS-CoV-2 Or Strong Response After Just One COVID-19 Vaccine Dose, Study Suggests

According to HealthDay (8/31, Preidt), a study published in Scientific Reports “shows that prior COVID-19 infection alone doesn’t guarantee a high level of antibodies against the coronavirus or a strong response after just one dose of two-dose vaccines.”...

Full Article

Request a Call from Customer Relations

Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id

First Name *
Last Name *
Email *
Customer ID

Administration Will Make Coronavirus Vaccines “Immediately Available” To Children Under 12 Once FDA Authorized, CDC Head Says

SARS-CoV-2 Antibody Testing: Where Are We Now?

Stat Laboratory Interventions To Improve Patient Management In The Emergency Department And Resource Expenditure: A 10-Year Study

Comparison Of Anti–SARS-CoV-2 S1 Receptor-Binding Domain Antibody Immunoassays In Health Care Workers Before And After The BNT162b2 MRNA Vaccine

WHO Monitoring Novel SARS-CoV-2 “Variant Of Interest”

Results Of Self-Collected ANS, Saliva Samples Obtained Within Three To Seven Days Of COVID-19 Symptom Onset Show Sensitivity Of 80% Or Higher, Study Finds

PEN-FAST Clinical Decision Tool May Assist In Efficient Amoxicillin Allergy Assessment, Results Show

WHO Says More Tests Reveal Ivory Coast Did Not Have Ebola Case

Dolutegravir, NRTI Combination Effective Second-Line Treatment For Patients With HIV Infection, Results Show

People Who Experience Breakthrough Infections After Full Vaccination About 50% Less Likely To Experience Long COVID, Study Finds

Study Suggests Surgical Masks Limit COVID-19 Seroprevalence

Most Highly Allergic Individuals Can Be Safely Immunized Against COVID-19, Data Show

Some Physicians, Health Authorities Concerned With “Craze” For Ivermectin As COVID-19 Treatment

Drugmakers Announce New Trials For COVID-19 Drugs

HIV Vaccine Trial Shut Down After Shots Found To Offer Limited Protection

Assay Shows High Accuracy Rate For Detecting Presence Of Bacterial, Viral Infections In Patients Admitted To ED With Suspected Acute Infections Or Sepsis, Results Indicate

Molecule In Brazilian Viper Venom Inhibits Coronavirus Reproduction In Monkey Cells, Study Shows

Highly Mutated C.1.2 COVID-19 Variant Does Not Appear To Be Spreading, WHO Says

Moderna COVID-19 Vaccine Creates Double The Antibodies Of Pfizer/BioNTech Shot, Study Finds

Prior COVID-19 Infection Alone May Not Guarantee High Level Of Antibodies Against SARS-CoV-2 Or Strong Response After Just One COVID-19 Vaccine Dose, Study Suggests